journal article·2025-01-08

Amphiphilic Photoluminescent Porous Silicon Nanoparticles as Effective Agents for Ultrasound-Amplified Cancer Therapy

Maxim B. Gongalsky, Uliana A. Tsurikova, Andrey A. Kudryavtsev, Nikolay V. Pervushin, Andrey P. Sviridov, Tushar Kumeria, Victoria D. Egoshina, Pyotr A. Tyurin-Kuzmin, Ilia A. Naydov, Kirill A. Gonchar, Gelina S. Kopeina, Valery G. Andreev, Boris Zhivotovsky, Liubov A. Osminkina

Publisher page

Abstract

This study investigates the use of photoluminescent amphiphilic porous silicon nanoparticles (αϕ-pSiNPs) as effective ultrasound (US) amplifiers for cancer sonodynamic theranostics. αϕ-pSiNPs were synthesized via a novel top-down approach involving porous silicon (pSi) films electrochemical etching, borate oxidation, and hydrophobic coating with octadecylsilane (C18), resulting in milling into nanoparticles with hydrophilic exteriors and hydrophobic interiors. These properties promote gas trapping and cavitation nucleation, significantly lowering the US cavitation threshold and resulting in selective destruction of cancer cells in the presence of nanoparticles. Efficient internalization of αϕ-pSiNPs in cell cytoplasm was demonstrated by their intrinsic photoluminescence, activated by partial oxidation of mesoporous silicon films in borate solutions, which resulted in quantum confinement of excitons in 2-5 nm Si quantum dots/wires. Combined with US exposure above the cavitation threshold, αϕ-pSiNPs caused a significant decrease in cell viability through mechanical stretching and microflows generated by oscillating microbubbles. Meanwhile, αϕ-pSiNPs exhibit high biocompatibility up to concentrations of 1 mg/mL without US activation. Their photoluminescent properties facilitate bioimaging, while their US contrast capabilities may enhance both imaging and therapy. The dual functionality of αϕ-pSiNPs supports a theranostic approach, enabling simultaneous diagnostics and treatment with a single agent. This study underscores the potential of αϕ-pSiNPs in sonodynamic therapy and bioimaging, offering a promising strategy for effective and safe anticancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Silicon Nanostructures and Photoluminescence · Nanoplatforms for cancer theranostics · Nanowire Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Physics, Lomonosov Moscow State University, Leninskie Gory 1, 119991 Moscow, Russian Federation

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Melbourne, VIC 3052, Australia

Faculty of Medicine, Lomonosov Moscow State University, Leninskie Gory 1, 119991 Moscow, Russian Federation

Engelhardt Institute of Molecular Biology, Russian Academy of Science, 119991 Moscow, Russia

School of Materials Science and Engineering, The University of New South Wales, Sydney, NSW 2052, Australia

Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, Stockholm SE-171 77, Sweden

Funding

Russian Science Foundation

References (55)

Show source-provided references
1. 10.3109/02656736.2014.96978910.3109/02656736.2014.969789 ↗
2. 10.1002/anie.20190682310.1002/anie.201906823 ↗
3. 10.1002/admt.20210088510.1002/admt.202100885 ↗
4. 10.3390/pharmaceutics1210096410.3390/pharmaceutics12100964 ↗
5. 10.3390/cells811142810.3390/cells8111428 ↗
6. 10.1038/s41598-019-46832-210.1038/s41598-019-46832-2 ↗
7. 10.1093/neuonc/noab196.24710.1093/neuonc/noab196.247 ↗
8. 10.1016/j.ultsonch.2004.03.00410.1016/j.ultsonch.2004.03.004 ↗
9. 10.1016/j.ccr.2021.21408710.1016/j.ccr.2021.214087 ↗
10. 10.1063/1.493172810.1063/1.4931728 ↗
11. 10.1016/j.micromeso.2015.02.03710.1016/j.micromeso.2015.02.037 ↗
12. 10.1021/acsami.7b1100710.1021/acsami.7b11007 ↗
13. 10.3389/fchem.2019.0039310.3389/fchem.2019.00393 ↗
14. 10.2147/IJN.S21218410.2147/IJN.S212184 ↗
15. 10.1038/s41551-021-00697-x10.1038/s41551-021-00697-x ↗
16. 10.1039/c2nr31002c10.1039/c2nr31002c ↗
17. 10.1002/adfm.20180576410.1002/adfm.201805764 ↗
18. 10.1063/1.493773110.1063/1.4937731 ↗
19. 10.1007/s00340-011-4562-810.1007/s00340-011-4562-8 ↗
20. 10.1021/nn103526210.1021/nn1035262 ↗
21. 10.1103/PhysRevLett.89.13740110.1103/PhysRevLett.89.137401 ↗
22. 10.1039/C6NH00082G10.1039/C6NH00082G ↗
23. 10.1038/nmat239810.1038/nmat2398 ↗
24. 10.1038/ncomms332610.1038/ncomms3326 ↗
25. 10.1002/adfm.20140058710.1002/adfm.201400587 ↗
26. 10.1002/adma.20180287810.1002/adma.201802878 ↗
27. 10.1021/cm500797b10.1021/cm500797b ↗
28. 10.1007/s11060-020-03536-210.1007/s11060-020-03536-2 ↗
29. 10.1016/j.biomaterials.2009.02.00810.1016/j.biomaterials.2009.02.008 ↗
30. 10.1088/0957-4484/18/18/18570410.1088/0957-4484/18/18/185704 ↗
31. 10.1016/j.nano.2016.04.00410.1016/j.nano.2016.04.004 ↗
32. 10.1016/j.colsurfb.2019.04.05010.1016/j.colsurfb.2019.04.050 ↗
33. 10.1002/ppsc.20130024410.1002/ppsc.201300244 ↗
34. 10.3389/fchem.2019.0016510.3389/fchem.2019.00165 ↗
35. 10.1103/PhysRevB.62.1594210.1103/PhysRevB.62.15942 ↗
36. 10.1103/PhysRevB.48.1102410.1103/PhysRevB.48.11024 ↗
37. 10.1039/D0FD00018C10.1039/D0FD00018C ↗
38. 10.1016/j.biomaterials.2010.11.01010.1016/j.biomaterials.2010.11.010 ↗
39. 10.1016/j.colsurfb.2020.11094610.1016/j.colsurfb.2020.110946 ↗
40. Salcedo W. J. · Braz. J. Phys. · 1997 · 27 · 158
41. 10.1021/j100182a06810.1021/j100182a068 ↗
42. 10.1021/jp963322r10.1021/jp963322r ↗
43. 10.1021/j150572a01210.1021/j150572a012 ↗
44. 10.1007/s10854-012-0934-z10.1007/s10854-012-0934-z ↗
45. 10.1021/la000206d10.1021/la000206d ↗
46. 10.1103/PhysRevB.55.926310.1103/PhysRevB.55.9263 ↗
47. 10.1121/1.38462410.1121/1.384624 ↗
48. 10.1016/j.ultsonch.2018.12.03110.1016/j.ultsonch.2018.12.031 ↗
49. 10.1121/1.191173510.1121/1.1911735 ↗
50. 10.1038/371346a010.1038/371346a0 ↗
51. 10.1016/j.cbi.2019.10877410.1016/j.cbi.2019.108774 ↗
52. 10.1002/adma.20190295210.1002/adma.201902952 ↗
53. 10.1021/acsami.0c0582710.1021/acsami.0c05827 ↗
54. 10.1121/1.191194010.1121/1.1911940 ↗
55. 10.1016/S0301-5629(96)00089-010.1016/S0301-5629(96)00089-0 ↗